Literature DB >> 25555869

The treatment of severe and multiple injuries in intensive care unit: report of 80 cases.

W Chen1, J Wang, Q L Feng, S C Xu, L Xiang, L Y Feng, Z L Chang, L Ba.   

Abstract

OBJECTIVE: To summarize our case load in managing severe and multiple injuries (SMI) in the Intensive Care Unit (ICU). PATIENTS AND METHODS: The clinical data of 80 SMI patients treated in our ICU from January 2009 to June 2013 were analyzed.
RESULTS: Results of these 80 SMI patients, 60 (75%) were salvaged and 15 (18.75%) died. The causes of death included severe head injury (n=7), severe chest injury (n=3), destruction of injured abdominal organs (n=2), and multiple organ dysfunction syndrome (n=3). Five patients (7.50%) gave up treatment and were discharged upon their own requests. Early application of continuous renal replacement therapy (CRRT) and enteral nutrition (EN) improved outcomes.
CONCLUSIONS: The key interventions during the ICU treatment of SMI include: adequate analgesia and appropriate sedation; timely management of hypoxemia; reasonable fluid resuscitation and CRRT.

Entities:  

Mesh:

Year:  2014        PMID: 25555869

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Therapeutic Effect and Prognosis of PiCCO in the Treatment of Myocardial Injury Complicated with Septic Shock.

Authors:  Xuan Lu; Huaixiang Zhai; Yue Dong; Fei Su; Yongpeng Xie; Yanli Wang; Lili Wang; Jiguang Li; Ping Xu
Journal:  Comput Math Methods Med       Date:  2022-06-06       Impact factor: 2.809

2.  Application strategy of PiCCO in septic shock patients.

Authors:  Xiaoyun Liu; Wenli Ji; Jifeng Wang; Tao Pan
Journal:  Exp Ther Med       Date:  2016-01-29       Impact factor: 2.447

Review 3.  Global changes in mortality rates in polytrauma patients admitted to the ICU-a systematic review.

Authors:  Johanna M M van Breugel; Menco J S Niemeyer; Roderick M Houwert; Rolf H H Groenwold; Luke P H Leenen; Karlijn J P van Wessem
Journal:  World J Emerg Surg       Date:  2020-09-30       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.